• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1992 - 1993年美国2岁儿童的疫苗接种覆盖率

Vaccination coverage of 2-year-old children--United States, 1992-1993.

出版信息

MMWR Morb Mortal Wkly Rep. 1994 Apr 22;43(15):282-3.

PMID:8164635
Abstract

The principal goal of the Childhood Immunization Initiative (CII) is to increase, by 1996, vaccination levels for 2-year-old children to at least 90% for the most critical doses in the vaccination series (i.e., one dose of measles-mumps-rubella vaccine [MMR] and at least three doses each of diphtheria and tetanus toxoids and pertussis vaccine [DTP], oral poliovirus vaccine [OPV], and Haemophilus influenzae type b vaccine [Hib]) and to at least 70% for at least three doses of hepatitis B vaccine (Hep B). Since 1991, annual national estimates of vaccination coverage levels of preschool-aged children have been available through the National Health Interview Survey (NHIS) conducted by CDC. This report presents vaccination coverage levels of children aged 19-35 months for 1992 and provisional estimates of vaccination coverage for the combined first and second quarters of 1993 (Table 1).

摘要

儿童免疫计划(CII)的主要目标是,到1996年,将2岁儿童针对疫苗接种系列中最关键剂量的疫苗接种率提高到至少90%(即一剂麻疹-腮腺炎-风疹疫苗[MMR]以及白喉、破伤风类毒素和百日咳疫苗[DTP]、口服脊髓灰质炎病毒疫苗[OPV]和b型流感嗜血杆菌疫苗[Hib]各至少三剂),并将至少三剂乙肝疫苗(Hep B)的接种率提高到至少70%。自1991年以来,可通过疾病控制和预防中心(CDC)开展的国家健康访谈调查(NHIS)获得全国学龄前儿童疫苗接种覆盖率的年度估计数据。本报告呈现了1992年19至35个月龄儿童的疫苗接种覆盖率以及1993年第一和第二季度合并后的疫苗接种覆盖率初步估计数据(表1)。

相似文献

1
Vaccination coverage of 2-year-old children--United States, 1992-1993.1992 - 1993年美国2岁儿童的疫苗接种覆盖率
MMWR Morb Mortal Wkly Rep. 1994 Apr 22;43(15):282-3.
2
Vaccination coverage of 2-year-old children--United States, 1993.1993年美国2岁儿童的疫苗接种覆盖率
MMWR Morb Mortal Wkly Rep. 1994 Oct 7;43(39):705-9.
3
Vaccination coverage of 2-year-old children--United States, January-March, 1994.1994年1月至3月美国2岁儿童的疫苗接种覆盖率
MMWR Morb Mortal Wkly Rep. 1995 Mar 3;44(8):142-3, 149-50.
4
Status report on the Childhood Immunization Initiative: national, state, and urban area vaccination coverage levels among children aged 19-35 months--United States, 1996.《儿童免疫计划现状报告:1996年美国19至35个月龄儿童的全国、各州及市区疫苗接种覆盖率》
MMWR Morb Mortal Wkly Rep. 1997 Jul 25;46(29):657-64.
5
Recommended childhood immunization schedule--United States, 1997.1997年美国推荐的儿童免疫接种程序表
MMWR Morb Mortal Wkly Rep. 1997 Jan 17;46(2):35-40.
6
From the Centers for Disease Control and Prevention. Vaccination coverage of 2-year-old children--United States, 1992-1993.来自疾病控制与预防中心。1992 - 1993年美国2岁儿童的疫苗接种覆盖率。
JAMA. 1994 May 11;271(18):1398.
7
[Preventive vaccination (DPT, HiB, polio, MMR) in hepatitis B virus carrier status?].乙肝病毒携带者状态下的预防性疫苗接种(百白破、b型流感嗜血杆菌疫苗、脊髓灰质炎疫苗、麻腮风疫苗)?
Kinderarztl Prax. 1993 Dec;61(10):376-7.
8
Impact of missed opportunities to vaccinate preschool-aged children on vaccination coverage levels--selected U.S. sites, 1991-1992.1991 - 1992年美国部分地区未接种学龄前儿童疫苗的机会对疫苗接种覆盖率的影响
MMWR Morb Mortal Wkly Rep. 1994 Oct 7;43(39):709-18.
9
[Cerebral seizures and/or encephalitis after MMR, oral polio, HiB or DPT vaccination?].[麻疹、腮腺炎、风疹联合疫苗、口服脊髓灰质炎疫苗、b型流感嗜血杆菌疫苗或百白破疫苗接种后出现的癫痫发作和/或脑炎?]
Kinderarztl Prax. 1993 Aug;61(6):232-4.
10
Recommended childhood immunization schedule--United States, 1998.1998年美国推荐的儿童免疫接种程序表
MMWR Morb Mortal Wkly Rep. 1998 Jan 16;47(1):8-12.

引用本文的文献

1
Highlights of historical events leading to national surveillance of vaccination coverage in the United States.美国国家疫苗接种覆盖率监测相关历史事件要点。
Public Health Rep. 2011 Jul-Aug;126 Suppl 2(Suppl 2):3-12. doi: 10.1177/00333549111260S202.
2
Vaccination coverage among U.S. children aged 19-35 months entitled by the Vaccines for Children program, 2009.2009 年美国儿童疫苗计划(Vaccines for Children program)覆盖的 19-35 个月龄儿童疫苗接种率。
Public Health Rep. 2011 Jul-Aug;126 Suppl 2(Suppl 2):109-23. doi: 10.1177/00333549111260S213.